Matches in Nanopublications for { ?s ?p "[Patients with interferon-associated type 1 diabetes retained higher levels of fasting serum C peptide as well as GAD65 antibodies than those with type 1A diabetes until 2 to 4 years after onset.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[Patients with interferon-associated type 1 diabetes retained higher levels of fasting serum C peptide as well as GAD65 antibodies than those with type 1A diabetes until 2 to 4 years after onset.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Patients with interferon-associated type 1 diabetes retained higher levels of fasting serum C peptide as well as GAD65 antibodies than those with type 1A diabetes until 2 to 4 years after onset.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP868016.RAelsYgGUeGCjP45ApStyLMqW-jS7AuuM4JBHONRlw6vE130_assertion description "[Patients with interferon-associated type 1 diabetes retained higher levels of fasting serum C peptide as well as GAD65 antibodies than those with type 1A diabetes until 2 to 4 years after onset.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP868016.RAelsYgGUeGCjP45ApStyLMqW-jS7AuuM4JBHONRlw6vE130_provenance.
- NP868015.RA0imYMs6jyR5AVLTf2gX-OY9tgSHqrlawlM77htujp_A130_assertion description "[Patients with interferon-associated type 1 diabetes retained higher levels of fasting serum C peptide as well as GAD65 antibodies than those with type 1A diabetes until 2 to 4 years after onset.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP868015.RA0imYMs6jyR5AVLTf2gX-OY9tgSHqrlawlM77htujp_A130_provenance.